Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (19)

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

2021

  1. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

2020

  1. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

2019

  1. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

  2. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain

    Odontology, Vol. 107, Núm. 4, pp. 530-535

2007

  1. Statin treatment withdrawal in ischemic stroke: A controlled randomized study

    Neurology, Vol. 69, Núm. 9, pp. 904-910

  2. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome

    Stroke, Vol. 38, Núm. 10, pp. 2759-2764

2006

  1. High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions

    Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 123-129

  2. Hyperthermia is a surrogate marker of inflammationmediated cause of brain damage in acute ischaemic stroke

    Journal of Internal Medicine, Vol. 260, Núm. 4, pp. 343-349

  3. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke

    Neurology, Vol. 67, Núm. 7, pp. 1172-1177

  4. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke

    Neurology, Vol. 67, Núm. 11, pp. 1973-1978

2005

  1. Increased plasma levels of 15-deoxy Δ prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke

    Stroke, Vol. 36, Núm. 6, pp. 1189-1194

  2. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers

    Stroke, Vol. 36, Núm. 9, pp. 1921-1926

2004

  1. Modelos experimentales en cefaleas

    Neurologia

2003

  1. L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: A clinical and experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 23, Núm. 8, pp. 978-984

  2. Modelos experimentales de cefaleas

    Neurologia, Vol. 18, Núm. 8, pp. 452-461

  3. Neuroprotective effects of aspirin in patients with acute cerebral infarction

    Neuroscience Letters, Vol. 339, Núm. 3, pp. 248-250

  4. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke

    Stroke, Vol. 34, Núm. 1, pp. 40-45

  5. The Release of Tumor Necrosis Factor-α is Associated with Ischemic Tolerance in Human Stroke

    Annals of Neurology, Vol. 54, Núm. 6, pp. 811-819